Mike Doustdar
Mike Doustdar has been appointed as the new CEO of Novo Nordisk, taking over from Lars Fruergaard Jørgensen on August 7, following a significant downward revision of the company's sales and operating profit expectations for 2025.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Denmark:
Mike Doustdar, the CEO of Novo Nordisk, criticized the Wegovy pill copy from Hims and Hers as a waste of money.
3
Denmark:
Mike Doustdar explains the challenges Novo Nordisk faces in increasing revenue due to market competition and pricing pressures.
6
Denmark:
Mike Doustdar, the CEO of Novo Nordisk, explained that the forecast is a result of the company lowering prices on its products significantly.
5
Denmark:
Mike Doustdar explains the challenges Novo Nordisk faces in increasing revenue due to market competition and pricing pressures.
7
Denmark:
Mike Doustdar, the CEO of Novo Nordisk, explained that the forecast is a result of the company significantly lowering prices on its products.
6
Australia:
Chief executive Mike Doustdar said in a statement that Novo Nordisk will face pricing headwinds in an increasingly competitive market.
5
Denmark:
Mike Doustdar is the CEO of Novo Nordisk and acknowledges the challenges the company faces in 2026.
5
Hungary:
Mike Doustdar, the CEO of Novo Nordisk, stated that patients will receive a convenient daily tablet that can help lose as much weight as the original Wegovy injection.
8
United States:
Mike Doustdar, president and CEO of Novo Nordisk, stated that the Wegovy pill can help patients lose as much weight as the original Wegovy injection.
8
Cabo Verde:
Mike Doustdar is the president of the pharmaceutical company Novo Nordisk, which announced the approval of a new oral treatment for obesity.
8